insights_auto
Why is KROS down 2.82%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.04
arrow_downward
-2.82%(-0.32) 1D
Oct 30, 3:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Is the Vanguard S&P 500 ETF Still a Buy for Long-Term Investors? Here's My Honest Take.
BigGo Finance
·
10 hours ago
Nasdaq's 5.3% October Swoon: AI Capex Fears Meet a History of 24% Rebound Years
TradingView
·
4 hours ago
Morgan Stanley's Wilson sees 9% S&P 500 drop before rally to 8,000
Traders Union
·
4 hours ago
S&P 500 fell 0.93 percent as 9 of 11 sectors gained, Stephanie Link notes
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com